LCFY vs. VOR

Last updated Apr 1, 2026

Compare and contrast key facts about Locafy Ltd (LCFY) and Vor Biopharma Inc. (VOR).

Performance

LCFY vs. VOR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Locafy Ltd (LCFY) and Vor Biopharma Inc. (VOR). The values are adjusted to include any dividend payments, if applicable.

LCFY vs. VOR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
LCFY Locafy Ltd	55.71%	-59.24%	-24.30%	53.82%	-91.17%
VOR Vor Biopharma Inc.	36.39%	-41.08%	-50.67%	-66.17%	-1.92%

Fundamentals

Market Cap LCFY : $7.92M VOR : $176.11M
EPS LCFY : -$1.44 VOR : -$91.51
Total Revenue (TTM) LCFY : $3.63M VOR : $0.00
Gross Profit (TTM) LCFY : $3.63M VOR : $0.00
EBITDA (TTM) LCFY : -$803.06K VOR : -$371.64M

Returns By Period

In the year-to-date period, LCFY achieves a 55.71% return, which is significantly higher than VOR's 36.39% return.

LCFY

• 1D: 3.81%
• 1M: -8.02%
• YTD: 55.71%
• 6M: -40.44%
• 1Y: -3.33%
• 3Y*: -12.37%
• 5Y*: —
• 10Y*: —

VOR

• 1D: 21.36%
• 1M: 15.54%
• YTD: 36.39%
• 6M: -63.38%
• 1Y: 24.32%
• 3Y*: -45.06%
• 5Y*: -52.97%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

LCFY vs. VOR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LCFY

LCFY Risk / Return Rank: 55
LCFY Sharpe Ratio Rank: 40
LCFY Sortino Ratio Rank: 83
LCFY Omega Ratio Rank: 79
LCFY Calmar Ratio Rank: 36
LCFY Martin Ratio Rank: 37

VOR

VOR Risk / Return Rank: 59
VOR Sharpe Ratio Rank: 46
VOR Sortino Ratio Rank: 76
VOR Omega Ratio Rank: 79
VOR Calmar Ratio Rank: 47
VOR Martin Ratio Rank: 45

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LCFY vs. VOR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Locafy Ltd (LCFY) and Vor Biopharma Inc. (VOR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	LCFY	VOR	Difference
Sharpe ratio Return per unit of total volatility	-0.01	0.13	-0.14
Sortino ratio Return per unit of downside risk	2.28	1.89	+0.38
Omega ratio Gain probability vs. loss probability	1.28	1.27	0.00
Calmar ratio Return relative to maximum drawdown	-0.18	0.21	-0.39
Martin ratio Return relative to average drawdown	-0.28	0.32	-0.60
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

LCFY vs. VOR - Sharpe Ratio Comparison

The current LCFY Sharpe Ratio is -0.01, which is lower than the VOR Sharpe Ratio of 0.13. The chart below compares the historical Sharpe Ratios of LCFY and VOR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	LCFY	VOR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.01	0.13	-0.14
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.45	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.28	-0.44	+0.16

Correlation

The correlation between LCFY and VOR is 0.07, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

LCFY vs. VOR - Dividend Comparison

Neither LCFY nor VOR has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

LCFY vs. VOR - Drawdown Comparison

The maximum LCFY drawdown since its inception was -96.59%, roughly equal to the maximum VOR drawdown of -99.72%. Use the drawdown chart below to compare losses from any high point for LCFY and VOR.

Drawdown Indicators

	LCFY	VOR	Difference
Max Drawdown Largest peak-to-trough decline	-96.59%	-99.72%	+3.13%
Max Drawdown (1Y) Largest decline over 1 year	-68.07%	-87.15%	+19.08%
Max Drawdown (5Y) Largest decline over 5 years	—	-99.61%	—
Current Drawdown Current decline from peak	-93.47%	-98.35%	+4.88%
Average Drawdown Average peak-to-trough decline	-88.61%	-88.36%	-0.25%
Ulcer Index Depth and duration of drawdowns from previous peaks	43.56%	57.88%	-14.32%

Volatility

LCFY vs. VOR - Volatility Comparison

The current volatility for Locafy Ltd (LCFY) is 22.77%, while Vor Biopharma Inc. (VOR) has a volatility of 29.30%. This indicates that LCFY experiences smaller price fluctuations and is considered to be less risky than VOR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LCFY	VOR	Difference
Volatility (1M) Calculated over the trailing 1-month period	22.77%	29.30%	-6.53%
Volatility (6M) Calculated over the trailing 6-month period	70.56%	104.24%	-33.68%
Volatility (1Y) Calculated over the trailing 1-year period	253.09%	187.43%	+65.66%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	179.42%	117.27%	+62.15%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	179.42%	118.05%	+61.37%

Financials